Search Ontology:
ChEBI

alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc6S

Term ID
CHEBI:71603
Synonyms
  • 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-6-O-sulfo-alpha-D-galactopyranose
  • alpha-D-galactopyranose, O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-, 6-(hydrogen sulfate)
  • alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-6-O-sulfo-alpha-D-galactosamine
  • alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc6S
  • Neu5Aca2-3Galb1-3(6S)GalNAca
  • Neu5Acalpha2-3Galbeta1-3[6OSO3]GalNAcalpha
  • O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->3)-O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranose, 6-(hydrogen sulfate)
Definition
A linear amino trisaccharide comprising N-acetyl-α-neuraminic acid, β-D-galactose and N-acetyl-6-O-sulfo-α-D-galactosamine residues linked sequentially (2→3) and (1→3).
References
  • glygen:G92252GS
  • glytoucan:G92252GS
  • pubmed:19443021
  • pubmed:25568069
  • pubmed:31537530
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc6S
Phenotype where environments contain alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc6S
Phenotype modified by environments containing alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc6S
Phenotype affecting alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->3)-alpha-D-GalpNAc6S
Human Disease Model